(Q33772812)

29 July 2017

1 reference

title

Update on Alzheimer's disease. Promising advances in detection and treatment (English)

1 reference

29 July 2017

0 references

J R Burke

1

1 reference

29 July 2017

J C Morgenlander

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

29 July 2017

published in

Postgraduate Medicine

1 reference

29 July 2017

volume

106

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

85-6, 89-90, 93-4 passim

1 reference

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.10.15.746

Apolipoprotein E and the CNS response to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.10.15.746

Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.10.15.746

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.10.15.746

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.10.15.746

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.10.15.746

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.10.15.746

Clinical trial of indomethacin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.10.15.746

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.1999.10.15.746

10.3810/PGM.1999.10.15.746

21 January 2018

Identifiers

DOI

1 reference

release_bo7ebpo4yngn5bzjyz3dmlb4zy

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bo7ebpo4yngn5bzjyz3dmlb4zy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference